Genetics company 23andMe is considering splitting up the company to boost its stock price after reporting a decrease in revenue from $67 million to $45 million. The company, once valued at $6 billion, now has a stock price worth less than a dollar. CEO Anne Wojcicki aims to steer the struggling DNA-testing company towards profitability.
How 23AndMe Went From a $6 Billion Valuation to a Penny Stock 🧬💸 https://t.co/7bAFsXfYJC
23andMe’s CEO Anne Wojcicki has saved the genetics company from the brink of failure before. She sat down with WIRED to talk about where it goes from here. https://t.co/MEVTPFcLsJ
Watch: 23andMe was valued at $6 billion in 2021, now its stock price is worth less than a dollar. Here’s why the once-hot DNA-testing company is struggling to profit. https://t.co/62WA1JHd3F https://t.co/62WA1JHd3F
$ME 23andMe reported revenue of $45 million for the quarter, down from the $67 million it reported in the same period last year. They are going to split the company. What would that do? Two bad companies instead of one.
23andMe considers splitting up company to revive stock price https://t.co/ROPcHyeanS